1.
Dokl Biochem Biophys
; 485(1): 126-128, 2019 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31201631
RESUMO
We generated a novel human neutralizing human mAb RabD4 against rabies virus glycoprotein using in vitro stimulation of human peripheral B cells produced by immunized donor. The human mAb RabD4 showed a high antigen-binding activity and virus-neutralizing activity in the FAVN test with the CVS-11 rabies virus.